Navigation Links
Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth
Date:10/5/2010

this regard, for Generex Oral-lyn™ as well as other diabetic and energy related pipeline products using the buccal delivery platform technologies.

The third prong to our strategy is to work with other pharmaceutical companies to establish the use of our proprietary liquid formulations that allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using our proprietary RapidMist™ device.  By using RapidMist™ as a delivery method, we believe we can extend the patent life of injectable drugs near the end of their patent protection, greatly enhancing the value of those drugs.

For our immunotherapeutic vaccine platform, under development at our wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), we are confident that fiscal 2011 will be a year of great advancement in these groundbreaking efforts.  We believe the vast potential of our breast, prostate, and other AE37 cancer vaccines are unmined gems for our Company.  AE37 is used to generate a specific immunological response to cancers expressing the HER2 oncogene.  We are in the midst of a Phase II clinical trial in patients with breast cancer and a Phase I trial in patients with ovarian cancer.  In addition, we recently completed a Phase I trial in patients with prostate cancer and are making preparations to move into a Phase II trial.  We anticipate our Phase II AE37 trial in breast cancer will be completed in fiscal 2011 and, provided that the study data is consistent with data available to date, we intend to work with the FDA on a plan to conduct a Phase III study for this important vaccine.

We have recently looked to augment our team of scientific advisors as we move our development programs and pipeline of products toward commercialization.  We intend to take advantage of their experience and expertise to assist our scientifi
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Generex Announces Presentations of Novel Vaccine Strategies
4. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
5. Generex Announces Sales Agreement with Elias Shaker & Company
6. Generex Presents Abstract at EASD Annual Meeting
7. Generex Awarded a New Patent in Canada for its Proprietary Buccal Drug Delivery System
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
10. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
11. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... Calif. , March 2, 2015 Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that Brad Vale , PhD, DVM, former ... been appointed to its Board of Directors, effective March ... 30 years of experience in developing, commercializing and investing ...
(Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2
... 10 Biopure Corporation,(Nasdaq: BPUR ) today announced ... have been published in the June 2008 issue of,the ... an Alternative,to Blood Transfusion: Efficacy and Safety Evaluation in ... "It is gratifying to have experts cull through the ...
... Endpoints for Advair Diskus(R) ... Compared to ... African American,patients with asthma treated with Advair Diskus, a combination ... propionate, had a lower rate of exacerbations when,compared with patients ...
Cached Medicine Technology:Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 3
(Date:3/2/2015)... Today the Brain Injury Association of America (BIAA) officially kicked ... support the more than 5.3 million Americans who are living ... nation in observing Brain Injury Awareness Month by conducting an ... the 2015 to 2017 campaign is: Not Alone. , ... general public about the incidence of brain injury and the ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy ... Global Industry Analysts Inc and recently added to its ... . Through 2018, the global radiation therapy equipment market ... research report suggests a holistic analysis of the situation ... well as covers the top market trends. The publication ...
(Date:3/2/2015)... 02, 2015 Tyrone Christopher, Co-founder of ... medium for the model agency industry, have launched Softcandy.sexy, ... Mango, Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla ... 1pm. , At a cost of alienating a few ... fire by announcing the brands commitment and support of ...
(Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
(Date:3/2/2015)... View, CA (PRWEB) March 02, 2015 ... today that it has officially launched a multivitamin ... Gustafsson, head of product development for BNatrl, said ... through feedback from Olympic and other world-class athletes. ... excited to use this pure whole food multivitamin ...
Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... ... a permanent solution to the Medicare physician payment system this year, says MedicareSupplementPlans.com ... Los ... year designed to improve the way Medicare pays physicians while still keeping Medicare costs ...
... , Senate Finance Committee Urged Not to Include ... WASHINGTON, Aug. 7 America,s local and regional independent ... provision imposing a 20% co-pay on laboratory services under Medicare. ... this provision would shift billions of dollars in costs to senior ...
... Duane Reade Holdings, Inc. announced today that its wholly-owned ... had closed their offering of $300.0 million aggregate principal amount ... The Notes bear interest at an annual rate of ... yield to maturity of 12.375%. The Notes were issued ...
... serious cardiovascular issues: study , FRIDAY, Aug. 7 (HealthDay ... is a reliable predictor of cardiovascular complications in people ... -- kidney damage caused by diabetes. , The study ... 2007. Those with increased levels of IgM in their ...
... , , , ... will learn how to use the latest technology to help keep ... California Partnership to End Domestic Violence (CPEDV) and Verizon. , ... the Verizon Foundation, the philanthropic arm of Verizon, is designed to ...
... the Yerkes National Primate Research Center, Emory University, believe ... explored in the development of an effective AIDS vaccine. ... nonhuman primates, they propose an additional new approach to ... in the August issue of Nature Medicine . ...
Cached Medicine News:Health News:Congress Unlikely to Pass Permanent Medicare Physician Payment Fix in 2009, says MedicareSupplementPlans.com 2Health News:Seniors: Get Your Checkbooks Ready 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 3Health News:Immunoglobulin Can Predict Some Diabetic Complications 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 3Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 4Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3
Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
Medicine Products: